phenytoin has been researched along with Anasarca in 30 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Purple glove syndrome is a rare and poorly understood complication of phenytoin use, occurring almost always with its intravenous formulation." | 7.81 | Purple glove syndrome occurring after oral administration of phenytoin in therapeutic doses: mechanism still a dilemma. ( Handa, R; Jain, RS; Kumar, S; Nagpal, K; Prakash, S, 2015) |
| "Purple glove syndrome is an uncommon but dreaded complication of intravenous phenytoin administration characterised by pain, oedema and purple-blue discolouration of the limb distal to the site of injection." | 7.78 | Purple glove syndrome: a dreadful complication of intravenous phenytoin administration. ( Garg, RK; Lalla, R; Malhotra, HS; Sahu, R, 2012) |
| "Purple glove syndrome (PGS) is a rare complication of intravenous phenytoin use that typically presents with pain, edema, and discoloration at the injection site that spreads to the distal limb." | 7.74 | Purple glove syndrome following intravenous phenytoin administration. ( Chokshi, R; Mehta, NN; Mohler, E; Openshaw, J, 2007) |
| "A 71-year-old male with history of epilepsy was admitted for seizures and traumatic brain injury and intravenous fosphenytoin and levetiracetam were initiated." | 3.85 | Fosphenytoin-induced purple glove syndrome: A case report. ( Blunck, JR; Croom, JE; Fields, RK; Newman, JW, 2017) |
| "Purple glove syndrome is a rare and poorly understood complication of phenytoin use, occurring almost always with its intravenous formulation." | 3.81 | Purple glove syndrome occurring after oral administration of phenytoin in therapeutic doses: mechanism still a dilemma. ( Handa, R; Jain, RS; Kumar, S; Nagpal, K; Prakash, S, 2015) |
| "Purple glove syndrome is an uncommon but dreaded complication of intravenous phenytoin administration characterised by pain, oedema and purple-blue discolouration of the limb distal to the site of injection." | 3.78 | Purple glove syndrome: a dreadful complication of intravenous phenytoin administration. ( Garg, RK; Lalla, R; Malhotra, HS; Sahu, R, 2012) |
| "Purple glove syndrome (PGS) is a rare complication of intravenous phenytoin use that typically presents with pain, edema, and discoloration at the injection site that spreads to the distal limb." | 3.74 | Purple glove syndrome following intravenous phenytoin administration. ( Chokshi, R; Mehta, NN; Mohler, E; Openshaw, J, 2007) |
| "PGS is a poorly understood, potentially serious local complication of IV phenytoin administration characterized by progressive distal limb edema, discoloration, and pain." | 3.70 | Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. ( Cascino, GD; Hanna, DR; O'Brien, TJ; So, EL, 1998) |
| "From April 8, 1982, through June 1984, 11 patients in a single hospital experienced 17 episodes of limb edema and discoloration after the intravenous (IV) administration of phenytoin sodium (Dilantin)." | 3.67 | Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors. ( Arrowsmith, JB; Buchanan, C; Graham, DR; Kilarski, DJ; Spengler, RF; Von Behren, L, 1988) |
| "Phenytoin (PHT) has been widely used intravenously for the treatment of seizures since 1956, and for many years, it has been considered first-line therapy for status epilepticus." | 2.70 | A prospective study of the incidence of the purple glove syndrome. ( Anandan, JV; Barkley, GL; Burneo, JG, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (33.33) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 12 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulloora, S | 1 |
| Shabaraya, R | 1 |
| Ranganathan, R | 1 |
| Adhikari, AV | 1 |
| Tsang, CY | 1 |
| Ng, JYW | 1 |
| Yuen, SH | 1 |
| Lau, IT | 1 |
| Leung, YF | 1 |
| Newman, JW | 1 |
| Blunck, JR | 1 |
| Fields, RK | 1 |
| Croom, JE | 1 |
| Ulubaş Işık, D | 1 |
| Demirel, N | 1 |
| Erol, S | 1 |
| Ünal, S | 1 |
| Baş, AY | 1 |
| Jain, RS | 1 |
| Nagpal, K | 1 |
| Kumar, S | 1 |
| Prakash, S | 1 |
| Handa, R | 1 |
| Shah, AM | 1 |
| Dahodwala, A | 1 |
| Abdel-Aziz, AA | 1 |
| El-Azab, AS | 1 |
| Abou-Zeid, LA | 1 |
| ElTahir, KE | 1 |
| Abdel-Aziz, NI | 1 |
| Ayyad, RR | 1 |
| Al-Obaid, AM | 1 |
| Warnecke, IC | 1 |
| Raute-Kreinsen, U | 1 |
| Schirmer, S | 1 |
| Kretschmer, F | 1 |
| Fansa, H | 1 |
| Chernoff, N | 1 |
| Rogers, JM | 1 |
| Prince, NJ | 1 |
| Hill, C | 1 |
| Wongkitisophon, P | 1 |
| Chanprapaph, K | 1 |
| Rattanakaemakorn, P | 1 |
| Vachiramon, V | 1 |
| Lalla, R | 1 |
| Malhotra, HS | 1 |
| Garg, RK | 1 |
| Sahu, R | 1 |
| Kirsch, S | 1 |
| Bayard, M | 1 |
| Darraj, K | 1 |
| Chokshi, R | 1 |
| Openshaw, J | 1 |
| Mehta, NN | 1 |
| Mohler, E | 1 |
| Cadenbach, A | 1 |
| Röttger, K | 1 |
| Müller, MK | 1 |
| O'Brien, TJ | 2 |
| Cascino, GD | 1 |
| So, EL | 1 |
| Hanna, DR | 1 |
| Coplin, WM | 1 |
| Rhoney, DH | 1 |
| Lyons, EA | 1 |
| Murry, KR | 1 |
| Yoshikawa, H | 1 |
| Abe, T | 1 |
| Oda, Y | 1 |
| Burneo, JG | 1 |
| Anandan, JV | 1 |
| Barkley, GL | 1 |
| Meara, FM | 1 |
| Matthews, H | 1 |
| Vajda, FJ | 1 |
| Bosl, R | 1 |
| Shideman, JR | 1 |
| Meyer, RM | 1 |
| Buselmeier, TJ | 1 |
| von Hartitzsch, B | 1 |
| Kjellstrand, CM | 1 |
| Grinder, D | 1 |
| Guastella, CP | 1 |
| Pellegrino, M | 1 |
| Spengler, RF | 1 |
| Arrowsmith, JB | 1 |
| Kilarski, DJ | 1 |
| Buchanan, C | 1 |
| Von Behren, L | 1 |
| Graham, DR | 1 |
| Robinson, HM | 1 |
| Stone, JH | 1 |
| Chikhani, P | 1 |
| Mick, BA | 1 |
| Nakamura, H | 2 |
| Nakatsuji, K | 2 |
| Nakamura, K | 2 |
| Bianchi, C | 1 |
| Bonardi, G | 1 |
| Kadokawa, T | 1 |
| Roberts, HJ | 1 |
1 review available for phenytoin and Anasarca
| Article | Year |
|---|---|
Hypoxia and the Edema Syndrome: elucidation of a mechanism of teratogenesis.
Topics: Abnormalities, Drug-Induced; Animals; Blister; Chick Embryo; Cocaine; Edema; Epinephrine; Hematoma; | 2010 |
2 trials available for phenytoin and Anasarca
| Article | Year |
|---|---|
A prospective study of the incidence of the purple glove syndrome.
Topics: Aged; Anticonvulsants; Edema; Epilepsy; Female; Forearm; Hand; Humans; Incidence; Infusions, Intrave | 2001 |
Prospective study of local cutaneous reactions in patients receiving IV phenytoin.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Contusions; Edema; Epilepsy; Female; Humans; Incide | 2001 |
27 other studies available for phenytoin and Anasarca
| Article | Year |
|---|---|
Synthesis, anticonvulsant and anti-inflammatory studies of new 1,4-dihydropyridin-4-yl-phenoxyacetohydrazones.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Carrageenan; Disease Models, Anim | 2013 |
Purple glove syndrome caused by intravenous phenytoin: two case reports.
Topics: Administration, Intravenous; Aged, 80 and over; Anticonvulsants; Diagnosis, Differential; Edema; Fem | 2019 |
Fosphenytoin-induced purple glove syndrome: A case report.
Topics: Aged; Anticonvulsants; Edema; Epilepsy; Humans; Male; Phenytoin; Skin Diseases; Upper Extremity | 2017 |
A Rare Complication of Phenytoin Infusion in Newborn: Purple Glove Syndrome.
Topics: Anticonvulsants; Cesarean Section; Cyanosis; Edema; Epilepsy, Tonic-Clonic; Humans; Infant, Newborn; | 2017 |
Purple glove syndrome occurring after oral administration of phenytoin in therapeutic doses: mechanism still a dilemma.
Topics: Administration, Oral; Adult; Anticonvulsants; Cyanosis; Edema; Hand; Humans; Male; Phenytoin; Status | 2015 |
Purple glove syndrome following intravenous phenytoin.
Topics: Edema; Forearm; Hand; Humans; Infant, Newborn; Phenytoin; Skin | 2014 |
Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
Topics: Analgesics; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase | 2016 |
[Purple glove syndrome - a case report].
Topics: Adult; Anticonvulsants; Edema; Endometriosis; Epilepsy, Complex Partial; Erythema; Extravasation of | 2010 |
Purple glove syndrome following intravenous phenytoin administration.
Topics: Anticonvulsants; Child; Cyanosis; Edema; Female; Hand; Humans; Infusions, Intravenous; Phenytoin; St | 2011 |
Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Anti-HIV Agents; Anti-Inflammatory Agents; Anticonvulsa | 2012 |
Purple glove syndrome: a dreadful complication of intravenous phenytoin administration.
Topics: Administration, Intravenous; Adult; Anticonvulsants; Drug Eruptions; Edema; Encephalitis; Fatal Outc | 2012 |
Distal upper extremity edema and discoloration.
Topics: Aged; Arm; Diagnosis, Differential; Edema; Female; Humans; Hyperpigmentation; Injections, Intravenou | 2007 |
Purple glove syndrome following intravenous phenytoin administration.
Topics: Aged; Anticonvulsants; Cyanosis; Edema; Epilepsy, Tonic-Clonic; Hand; Humans; Infusions, Intravenous | 2007 |
["Purple glove syndrome." Severe soft tissue reaction following phenytoin infusion].
Topics: Adult; Anticonvulsants; Edema; Epilepsy, Tonic-Clonic; Female; Forearm; Humans; Inflammation; Infusi | 1998 |
Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Edema; Female; Forearm; Hand; Hu | 1998 |
Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin.
Topics: Anticonvulsants; Edema; Extremities; Humans; Injections, Intravenous; Pain; Phenytoin | 1999 |
Purple glove syndrome caused by oral administration of phenytoin.
Topics: Administration, Oral; Anticonvulsants; Child; Drug Overdose; Edema; Epilepsy; Extremities; Humans; M | 2000 |
Effects and complications of high efficiency dialysis.
Topics: Barbiturates; Blood Urea Nitrogen; Body Weight; Calcium; Creatinine; Edema; Headache; Humans; Hypote | 1975 |
Soft-tissue damage and intravenous phenytoin.
Topics: Aged; Diabetes Complications; Edema; Female; Humans; Injections, Intravenous; Phenytoin | 1988 |
Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors.
Topics: Age Factors; Aged; Cardiovascular Diseases; Catheterization; Connective Tissue Diseases; Edema; Fema | 1988 |
Exanthem due to diphenylhydantoin therapy.
Topics: Adolescent; Alkaline Phosphatase; Blood Chemical Analysis; Blood Urea Nitrogen; Drug Eruptions; Edem | 1970 |
[Use of sodium phenytoin in the treatment of periodontal diseases].
Topics: Adult; Age Factors; Aged; Edema; Female; Gingival Hypertrophy; Humans; Male; Massage; Middle Aged; O | 1972 |
Diphenylhydantoin and intermittent edema.
Topics: Adolescent; Edema; Female; Fingers; Humans; Leg; Phenytoin | 1973 |
Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. 3. Absorption, tissue distribution and metabolic fate.
Topics: Adrenal Glands; Animals; Anti-Inflammatory Agents; Carrageenan; Chromatography, Thin Layer; Dogs; Ed | 1970 |
Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Barbiturates; Blood Glucose; Cardiovascular System; | 1972 |
Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity.
Topics: Aminopyrine; Analgesics; Anaphylaxis; Animals; Anti-Inflammatory Agents; Aspirin; Bradykinin; Capill | 1970 |
An inquiry into the pathogenesis, rational treatment and prevention of multiple sclerosis, with emphasis upon the combined role of diabetogenic hyperinsulinism and recurrent edema.
Topics: Adult; Diet Therapy; Edema; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Male; Methylphe | 1966 |